Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 234 (8%)
Anticipated shortage: 20 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISEDRONATE 35MG TABLET Resolved 2018-08-21 2018-10-19 58626
APO-RISEDRONATE 35MG TABLET Resolved 2018-10-19 2018-12-21 64981
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2019-10-09 2019-11-04 95874
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2020-10-07 2020-12-29 125809
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2020-12-11 2021-01-20 130040
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2021-03-26 2021-04-12 136409
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2021-06-11 2021-07-26 140777
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2021-12-03 2021-12-20 150432
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Resolved 2022-11-04 2022-12-09 173823
APO-DEFERASIROX (TYPE J) 360MG TABLET Resolved 2024-02-09 2024-03-08 219141
APO-MYCOPHENOLIC ACID 360MG TABLET (ENTERIC-COATED) Actual shortage 2024-04-26 2024-04-26 226309
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-03-10 2017-04-01 384
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-25 2017-08-31 16942
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-07 2018-01-10 28553
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-02-01 2018-06-04 37966
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-12-19 2019-07-17 70146
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2020-06-04 2020-08-17 116542
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-09 2021-05-01 137261
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-09 2021-05-01 137264
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-05-07 2021-07-02 138963

Showing 1921 to 1940 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4915
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-DIPYRIDAMOLE 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-FUROSEMIDE 80MG TABLET Discontinued 2017-03-30 2018-02-05 4719
APO-SOTALOL 80MG TABLET Discontinued 2017-03-31 2018-12-07 4936
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40817
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40820
APO-ATORVASTATIN 80MG TABLET Discontinued 2018-09-07 2018-12-29 60285
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-ASA LD 81MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60252
COATED DAILY LOW DOSE ASA 81 MG 81MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-04 71083
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977

Showing 341 to 356 of 356